ask="24.75"
ask_size="200"
average_daily_volume="437720"
bid="16.14"
bid_size="5000"
book_value="8.12"
change="+0.20"
change_from_200_day_moving_average="-0.60"
change_from_50_day_moving_average="-0.56"
change_from_52_week_high="-4.89"
change_From_52_week_low="8.08"
change_in_percent="+1.03%"
close="19.68"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.29"
ebitda="-18.48M"
eps_estimate_current_year="-0.96"
eps_estimate_next_quarter="-0.20"
eps_estimate_next_year="-1.21"
ex_dividend_date="N/A"
float_shares="23627000"
high="19.74"
high_52_weeks="24.57"
last_trade_date="3/10/2017"
last_trade_price="19.68"
last_trade_size="33007"
last_trade_time="4:00pm"
low="19.25"
low_52_weeks="11.60"
market_capitalization="749.67M"
moving_average_200_day="20.28"
moving_average_50_day="20.24"
name="Retrophin
Inc."
notes="N/A"
one_year_target_price="33.33"
open="19.60"
pe_ratio="N/A"
peg_ratio="-1.01"
percent_change_from_200_day_moving_average="-2.95%"
percent_change_from_50_day_moving_average="-2.78%"
percent_change_from_52_week_high="-19.90%"
percent_change_from_52_week_low="+69.66%"
previous_close="19.48"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.40"
price_per_sales="5.55"
revenue="133.59M"
shares_outstanding="38093000"
short_ratio="16.58"
stock_exchange="NGM"
symbol="RTRX"
volume="412598"
weeks_range_52="11.60 - 24.57"
